ASPIRIN- acetylsalicylic acid tablet

Pays: États-Unis

Langue: anglais

Source: NLM (National Library of Medicine)

Ingrédients actifs:

ASPIRIN (UNII: R16CO5Y76E) (ASPIRIN - UNII:R16CO5Y76E)

Disponible depuis:

IBA Inc.

DCI (Dénomination commune internationale):

ASPIRIN

Composition:

ASPIRIN 15.6 g

Mode d'administration:

ORAL

Type d'ordonnance:

OTC

indications thérapeutiques:

To be used as an aid in the symptomatic relief of minor aches, joint and muscular pain, and to reduce elevated body temperature.

Statut de autorisation:

unapproved drug other

Résumé des caractéristiques du produit

ASPIRIN - ACETYLSALICYLIC ACID TABLET
IBA INC.
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
ASPIRIN BOLUSES
INDICATIONS
To be used as an aid in the symptomatic relief of minor aches, joint
and muscular pain, and to reduce
elevated body temperature.
DOSAGE
DAIRY CATTLE:
1 to 2 boluses two times daily. Discontinue if any unusual symptoms
should appear.
BEEF CATTLE AND HORSES:
1 to 3 boluses two or three times daily. Discontinue if any unusual
symptoms appear.
EACH BOLUS CONTAINS:
Acetylsalicylic Acid..........240 grs.
Do not store above 30 C (86 F).
Keep lid tightly closed and store in a dry place.
o
o
IBA Inc.
ASPIRIN
acetylsalicylic acid tablet
PRODUCT INFORMATION
PRODUCT T YPE
OTC ANIMAL DRUG
ITE M CODE (SOURCE )
NDC:29 9 8 3-270 7
ROUTE OF ADMINISTRATION
ORAL
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
ASPIRIN (UNII: R16 CO5Y76 E) (ASPIRIN - UNII:R16 CO5Y76 E)
ASPIRIN
15.6 g
PRODUCT CHARACTERISTICS
COLOR
white (WHITE)
S CORE
2 pieces
S HAP E
OVAL (OBLONG)
S IZ E
6 mm
FLAVOR
IMPRINT CODE
2
CONTAINS
PACKAG ING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START DATE
MARKETING END DATE
1
NDC:29 9 8 3-270 7-2
50 in 1 JAR
MARKETING INFORMATION
MARKE TING CATE GORY
APPLICATION NUMBE R OR MONOGRAPH CITATION
MARKE TING START DATE
MARKE TING END DATE
unappro ved drug o ther
0 9 /17/19 9 9
LABELER -
IBA Inc. (019494160)
Revised: 5/2012